Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway

Journal of Clinical Investigation

Volumn 102, Issue 4, 1998, Pages 716-727

  Koh, Jason S ^a   Lieberthal, Wilfred ^a   Heydrick, Stan ^a   Levine, Jerrold S ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

Albumin; Apoptosis; Factors serum; Lysophosphatidic acid; Macrophages; Phosphatidylinositol 3 kinase; Phospholipids; Survival

Indexed keywords

LYSOPHOSPHATIDIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; MACROPHAGE; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0032528851     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1002     Document Type: Article

References (76)

1. Majno, G., and I. Joris. 1995. Apoptosis, oncosis, and necrosis. Am. J. Pathol. 146:3-15.
2. Raff, M.C. 1992. Social controls on cell survival and cell death. Nature. 356:397-400.
3. Lieberthal, W., and J.S. Levine. 1996. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am. J. Physiol. 271 (Renal Fluid Electrolyte Physiol. 40):F477-F488.
4. Steller, H. 1995. Mechanisms and genes of cellular suicide. Science. 267: 1445-1449.
5. Savill, J., V. Fadok, P. Henson, and C. Haslett. 1993. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today. 14:131-136.
6. Evan, G.I., A.M. Wyllie, C.S. Gilbert, T.D. Littlewood, H. Land, M. Brooks, C.M. Waters, L.Z. Penn, and D.C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:119-128.
7. Thompson, E.B. 1994. Apoptosis and steroid hormones. Mol. Endocrinol. 8:665-673.
8. Duke, R.C., and J.J. Cohen. 1986. IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Rev. 5: 289-299.
9. Becker, S., M.K. Warren, and S. Haskill. 1987. Colony-stimulating factor-induced monocyte survival in differentiation into macrophages in serum-free cultures. J. Immunol. 139:3703-3709.
10. Mangan, D.F., G.R. Welch, and S.M. Wahl. 1991. Lipopolysaccharide, tumor necrosis factor-α, and IL-1β prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J. Immunol. 146:1541-1546.
11. Moolenaar, W.U. 1995. Lysophosphatidic acid, a multifunctional phospholipid messenger. J. Biol. Chem. 270:12949-12952.
12. Moolenaar, W.H. 1995. Lysophosphatidic acid signalling. Curr. Opin. Cell Biol. 7:203-210.
13. Jalink, K., P.L. Hordijk, and W.H. Moolenaar. 1994. Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator. Biochim. Biophys. Acta. 1198:185-196.
14. Eichholtz, T., K. Jalink, I. Fahrenfort, and W.H. Moolenaar. 1993. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 291:677-680.
15. Tokumura, A., M. Iimori, Y. Nishioka, M. Kitahara, M. Sakashita, and S. Tanaka. 1994. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am. J. Physiol. 267 (Cell Physiol. 36): C204-C210.
16. Tigyi, G., and R. Miledi. 1992. Lysophosphatitades bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells. J. Biol. Chem. 267:21360-21367.
17. Thumser, A.E.A., J.E. Voysey, and D.C. Wilton. 1994. The binding of lysophospholipids to rat liver fatty acid-binding protein and albumin. Biochem. J. 301:801-806.
18. Benton, A.M., J.M. Gerrard, T. Michiel, and S.E. Kindom. 1982. Are lysophosphatidic acids or phosphatidic acids involved in stimulus activation coupling in platelets? Blood. 60:642-649.
19. Tigyi, G., D.L. Dyer, and R. Miledi. 1994. Lysophosphatidic acid possesses dual action in cell proliferation. Proc. Natl. Acad. Sci. USA. 91:1908-1912.
20. van Corven, E.J., A. Groenink, K. Jalink, T. Eichholtz, and W.H. Moolenaar. 1989. Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell. 59:45-54.
21. van Corven, E.J., A. van Rijswijk, K. Jalink, R.L. van der Bend, W.J. van Blitterswijk, and W.H. Moolenaar. 1992. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Biochem. J. 281:163-169.
22. Ridley, A.J., and A. Hall. 1992. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 70:389-399.
23. van der Bend, R.L., J. Brunner, K. Jalink, E.J. van Corven, W.H. Moolenaar, and W.J. van Blitterswijk. 1992. Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid. EMBO J. 11:2495-2501.
24. Thomson, F.J., L. Perkins, D. Ahern, and M. Clark. 1994. Identification and characterization of a lysophosphatidic acid receptor. Mol. Pharmacol. 45: 718-728.
25. Hecht, J.H. J.A. Weiner, S.R. Post, and J. Chun. 1996. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 135:1071-1083.
26. Guo, Z., K. Liliom, D.J. Fischer, I.C. Bathurst, L.D. Tomei, M.C. Kiefer, and G. Tigyi. 1996. Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes. Proc. Natl. Acad. Sci. USA. 93:14367-14372.
27. Yao, R., and G.M. Cooper. 1995. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science. 267:2003-2006.
28. 2+-mobilizing stimulus for fibroblasts. Evidence for an extracellular site of action. J. Biol. Chem. 265:12232-12239.
29. Levine, J.S., B.J. Pugh, D. Hartwell, J.M. Fitzpatrick, A. Marshak-Rothstein, and D.I. Beller. 1993. IL-1 dysregulation is an intrinsic defect in macrophages from MRL autoimmune-prone mice. Eur. J. Immunol. 23:2951-2958.
30. Price, B.E., J. Rauch, M.A. Shia, M.T. Walsh, W. Lieberthal, H.M. Gilligan, T. O'Laughlin, J.S. Koh, and J.S. Levine. 1996. Antiphospholipid autoantibodies bind to apoptotic, but not nonapoptotic, thymocytes in a β2-glycoprotein I-dependent manner. J. Immunol. 157:2201-2208.
31. Mossman, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65: 55-63.
32. Hardy, R.W. 1986. Purification and characterization of monoclonal antibodies. In Handbook of Experimental Immunology, D.M. Weir, L.A. Herzenberg, C. Blackwell, and L.A. Herzenberg, editors. Blackwell Scientific Publications, Oxford. 13.1-13.13.
33. Goldstein, J.L., S.K. Basu, and M.S. Brown. 1983. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. 1983. Methods Enzymol. 98:241-260.
34. Frisch, S.M., and E. Ruoslahti. 1997. Integrins and anoikis. Curr. Opin. Cell Biol. 9:701-706.
35. Saifer, A., and L. Goldman. 1961. The free fatty acids bound to human serum albumin. J. Lipid Res. 2:268-270.
36. Naito, M., S. Umeda, T. Yamamoto, H. Moriyama, H. Umezu, G. Hasegawa, H. Usuda, L.D. Schultz, and K. Takahashi. 1996. Development, differentiation, and phenotypic heterogeneity of murine tissue macrophages. J. Leuk. Biol. 59:133-138.
37. Betsholtz, C., A. Johnsson, C.-H. Heldin, and B. Westermark. 1986. Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin. Proc. Natl. Acad. Sci. USA. 83: 6440-6444.
38. Minshall, C., S. Arkins, G.G. Freund, and K.W. Kelley. 1996. Requirement for phosphatidylinositol 3′ kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor. J. Immunol. 156:939-947.
39. Zamorano, J., H.Y. Wang, L.-M. Wang, J.H. Pierce, and A.D. Keegan. 1996. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. J. Immunol. 157:4926-4934.
40. Ui, M., T. Okada, K. Hazeki, and O. Hazeki. 1995. Wortmannin as a unique probe for an intracellular signalling protein phophoinositide 3-kinase. Trends Biochem. Sci. 20:303-307.
41. Vlahos, T.J., W.F. Matter, K.Y. Hui, and R.F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241-5248.
42. King, W.G., M.D. Mattaliano, T.O. Chan, P.N. Tsichlis, and J.S. Brugge, Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen activated protein kinase pathway activation. Mol. Cell. Biol. 17:4406-4418.
43. Chen, H.-C., P.A. Appeddu, H. Isoda, and J.-L. Guan. 1996. Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase. J. Biol. Chem. 271:26329-26334.
44. Khwaja, A., P. Rodriguez-Viciana, S. Wennström, P.H. Warne, and J. Downward. 1997. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16:2783-2793.
45. Weng, Q.-P., K. Andrabi, A. Klippel, M.T. Kozlowski, L.T. Lewis, and J. Avruch. 1995. Phosphatidylinositol 3-kinase signals activation of p70 S6 kinase in situ through site-specific p70 phosphorylation. Proc. Natl. Acad. Sci. USA. 92:5744-5748.
46. Chou, M.M., and J. Blenis. 1995. The 70kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling. Curr. Opin. Cell Biol. 7:806-814.
47. Chung, J., C.J. Kuo, G.R. Crabtree, and J. Blenis. 1992. Rapamycin-FKBP specifically blocks growth-dependent activation and signaling by the 70 kd S6 protein kinases. Cell. 69:1227-1236.
48. Dudek, H., S.R. Datta, T.F. Franke, M.J. Birnbaum, R. Yao, G.M. Cooper, R.A. Segal, D.R. Kaplan, and M.E. Greenberg. 1997. Regulation of neuronal survival by the serine-threonine kinase Akt. Science. 275:661-665.
49. del Peso, L., M. González-García, C. Page, R. Herrera, and G. Nuñez. 1997. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science. 278:687-689.
50. Datta, S.R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M.E. Greenberg. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 231-241.
51. Grammer, T.C., and J. Blenis. 1996. The serine protease inhibitors, tosylphenylalanine chloromethyl kelone and tosyllysine chloromethyl ketone, potently inhibit pp70s6k activation. J. Biol. Chem. 271:23650-23652.
52. Lornage, J., J.F. Guerin, J.C. Czyba, and Y. Menezo. 1983. Influence of cations and albumin on human spermatozoa. Arch. Androl. 10:119-125.
53. Burleson, R.L., D.B. Jones, A.M. Yenikomshian, C. Cornwall, C. DeVoe, and J. DeRito. 1978. Clinical renal preservation by cryoperfusion with an albumin perfusate: renal perfusion with albumin. Arch. Surg. 113:688-692.
54. Guilbert, L.J., and N.N. Iscove. 1976. Partial replacement of serum by selenite, transferrin, albumin and lecithin in haemopoietic cell cultures. Nature. 263:594-595.
55. Kumagai, N., N. Morii, K. Fujisawa, Y. Nemoto, and S. Narumiya. 1993. ADP-ribosylation of rho p21 inhibits lysophosphatidic acid-induced protein tyrosine phosphorylation and phosphatidylinositol 3-kinase activation in cultured Swiss 3T3 cells. J. Biol. Chem. 268:24535-24538.
56. Carpenter, C.L., and L.C. Cantley. 1996. Phosphoinositide 3-kinase and the regulation of cell growth. Biochim. Biophys. Acta. 1288:M11-M16.
57. Stoyanov, B., S. Volinia, T. Hanck, I. Rubio, M. Loubtchenkov, D. Malek, S. Stoyanova, B. Vanhaesebroeck, R. Dhand, B. Nürnberg, P. Gierschik, K. Seedorf, J.J. Hsuan, M.D. Waterfield, and R. Wetzker. 1995. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science. 269:690-693.
58. Zhang, J., J. Zhang, J.L. Benovic, M. Sugai, R. Wetzker, I. Gout, and S.E. Rittenhouse. 1995. Sequestration of a G-protein beta gamma subunit or ADP-ribosylation of Rho can inhibit thrombin-induced activation of platelet phosphoinositide 3-kinases. J. Biol. Chem. 270:6589-6594.
59. Stephens, L., A. Smrcka, F.T. Cooke, T.R. Jackson, P.C. Sternweis, and P.T. Hawkins. 1994. A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein βγ subunits. Cell. 77:83-93.
60. Thomason, P.A., S.R. James, P.J. Casey, and C.P. Downes. 1994. A G-prolein βγ-subunit-responsive phosphoinositide 3-kinase activity in human platelet cytosol. J. Biol. Chem. 269:16525-16528.
61. Toker, A., and L.C. Cantley. 1997. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature. 387:673-676.
62. Lopez-Ilasaca, M., P. Crespo, P.G. Pellici, J.S. Gutkind, and R. Wetzker. 1996. Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase γ. Science. 275:394-397.
63. Rodriguez-Viciana, P., P.H. Warne, R. Dhand, B. Vanhaesebroeck, I. Gout, M.J. Fry, M.D. Waterfield, and J. Downward. 1994. Phosphatidylinositol 3-OH kinase as a direct target of Ras. Nature. 370:527-532.
64. Lin, T.H., Q. Chen, A. Howe, and R.L. Juliano. 1997. Cell anchorage permits efficient signal transduction between Ras and its downstream kinases. J. Biol. Chem. 272:8849-8852.
65. McNamee, H.P., D.E. Ingber, and M.A. Schwartz. 1993. Adhesion to fibronectin stimulates inositol lipid synthesis and enhances PDGF-induced inositol lipid breakdown. J. Cell Biol. 121:673-678.
66. Chong, L.D., A. Traynor-Kaplan, G.M. Bokoch, and M.A. Schwartz. 1994. The small GTP-binding protein Rho regulates a phosphatidylinositol 4-phosphate 5-kinase in mammalian cells. Cell. 79:507-513.
67. Franke, T.F., S.-I. Yang, T.O. Chan, K. Datta, A. Kazlauskas, D.K. Morrison, D.R. Kaplan, and P.N. Tsichlis. 1995. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 81:727-736.
68. Burgering, B.M.Th., and P.J. Coffer. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 376:599-602.
69. Akimoto, K., R. Takahashi, S. Moriya, N. Nishioka, J. Takayanagi, K. Kimura, Y. Fukui, S.-i. Osada, K. Mizuno, S.-i. Hirai, et al. 1996. EGF or PDGF receptors activate atypical PKCλ through phosphatidylinositol 3-kinase. EMBO J. 15:788-798.
70. 3. J. Biol. Chem. 269:32358-32367.
71. Jefferies, H.B.J., C. Reinhard, S.C. Kozma, and G. Thomas. 1994. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. Proc. Natl. Acad. Sci. USA. 91:4441-4445.
72. Brown, E.J., P.A. Beal, C.T. Keith, J. Chen, T.-B. Shin, and S.L. Schreiber. 1995. Control of p70s6 kinase activity of FRAP in vivo. Nature. 377: 441-446.
73. Shi, Y., A. Frankel, L.G. Radvanyi, L.Z. Penn, R.G. Miller, and G.B. Mills. 1995. Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro. Cancer Res. 55:1982-1988.
74. Beg, A.A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 274:782.
75. Wang, C-Y., M.W. Mayo, and A.S. Baldwin, Jr. 1996. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science. 274: 784.
76. van Antwerp, D.J., S.J. Martin, T. Kafri, D.R. Green, and I.M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science. 274:787.